Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a global pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs, focusing on the research and development of new drugs in the fields of anti-tumor, surgical drugs, autoimmune diseases, metabolic diseases and cardiovascular diseases. Innovation is the core development strategy. Hengrui has 12 innovative products and 1 cooperative innovative product marketed, more than 60 innovative candidates in the R&D stage, and more than 260 trials under clinical development around the world. Hengrui ranked 24th among the top 1,000 global pharma companies announced by the Torreya in 2021. We have been on the Pharma Exec's annual listing of the top global pharmaceutical companies for the fourth consecutive year, rising from 47th in 2019 to 32nd in 2022.
该公司进入各个市场的顺序 — 从最早到最新
注册以查看完整信号动态
Hengrui Pharma Co.,Ltd 的国际扩张与竞争对手的对比情况
Hengrui Pharma Co.,Ltd你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Hengrui Pharma Co.,Ltd你 | 0 | 0 | 0% | 0 | 32 |
Director, Transaction Attorney
查看职位Shanghai, China · 去年
Pharmaceutical Ch
查看职位Jiangsu, China · 去年
临床管培生--肿瘤医学
查看职位Shanghai, China · 去年
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
没有近期新闻
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Hengrui Pharma Co.,Ltd 的业务、市场和增长信号的快速解答。
